INSMED Inc — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| SHAROKY MELVIN MD | — | Option Exercise | 5,469 | — | — | 86,637 | Jan 23, 2012 |
| Kollender Richard S | — | Option Exercise | 5,469 | — | — | 5,469 | Jan 23, 2012 |
| ENGELSEN STEINAR J | — | Option Exercise | 5,469 | — | — | 141,951 | Jan 23, 2012 |
| HAYDEN DONALD J JR | — | Option Exercise | 8,594 | — | — | 27,594 | Jan 23, 2012 |
| WHITCOMB RANDALL W | — | Option Exercise | 5,469 | — | — | 37,409 | Jan 23, 2012 |
| SHAROKY MELVIN MD | — | Purchase | 17,266 | $7.63 | $131,740 | 80,725 | Apr 11, 2011 |
| SHAROKY MELVIN MD | — | Purchase | 7,352 | $7.64 | $56,169 | 63,459 | Apr 8, 2011 |
| Whitten Timothy | President & CEO | Purchase | 2,500 | $6.58 | $16,450 | 2,500 | Mar 30, 2011 |
| HAYDEN DONALD J JR | — | Purchase | 2,200 | $6.36 | $13,992 | 12,937 | Mar 29, 2011 |
| GUPTA RENU | EVP & Chief Medical Officer | Purchase | 1,000 | $6.15 | $6,150 | 1,000 | Mar 28, 2011 |
| ENGELSEN STEINAR J | — | Purchase | 493 | $6.60 | $3,254 | 136,482 | Mar 28, 2011 |
| WHITCOMB RANDALL W | — | Purchase | 5,000 | $6.54 | $32,700 | 29,840 | Mar 28, 2011 |
| HAYDEN DONALD J JR | — | Purchase | 9,800 | $5.15 | $50,470 | 12,000 | Mar 25, 2011 |
| HAYDEN DONALD J JR | — | Purchase | 9,400 | $5.15 | $48,410 | 9,400 | Mar 25, 2011 |
| WHITCOMB RANDALL W | — | Purchase | 5,000 | $5.15 | $25,750 | 24,840 | Mar 23, 2011 |
| ENGELSEN STEINAR J | — | Purchase | 29,337 | $5.24 | $153,726 | 135,989 | Mar 23, 2011 |
| Kollender Richard S | — | Other | 17,072,989 | — | — | 17,072,989 | Mar 1, 2011 |
| CROOKE GRAHAM K | — | Award / Grant | 33,784 | — | — | 228,404 | Jun 9, 2010 |
| CONDON KENNETH G | — | Award / Grant | 33,784 | — | — | 168,504 | Jun 9, 2010 |
| SHAROKY MELVIN MD | — | Award / Grant | 33,784 | — | — | 561,074 | Jun 9, 2010 |
| WHITCOMB RANDALL W | — | Award / Grant | 33,784 | — | — | 198,404 | Jun 9, 2010 |
| ENGELSEN STEINAR J | — | Award / Grant | 33,784 | — | — | 266,529 | Jun 9, 2010 |
| Lanfear Dennis M | — | Award / Grant | 33,784 | — | — | 168,404 | Jun 9, 2010 |
| CROOKE GRAHAM K | — | Award / Grant | 14,620 | — | — | 194,620 | May 20, 2009 |
| Lanfear Dennis M | — | Award / Grant | 14,620 | — | — | 134,620 | May 20, 2009 |
| CONDON KENNETH G | — | Award / Grant | 14,620 | — | — | 134,720 | May 20, 2009 |
| WHITCOMB RANDALL W | — | Award / Grant | 14,620 | — | — | 164,620 | May 20, 2009 |
| SHAROKY MELVIN MD | — | Award / Grant | 14,620 | — | — | 527,290 | May 20, 2009 |
| ENGELSEN STEINAR J | — | Award / Grant | 14,620 | — | — | 232,745 | May 20, 2009 |
| ENGELSEN STEINAR J | — | Award / Grant | 120,000 | — | — | 218,125 | Mar 31, 2009 |
| CROOKE GRAHAM K | — | Award / Grant | 120,000 | — | — | 180,000 | Mar 31, 2009 |
| CONDON KENNETH G | — | Award / Grant | 120,000 | — | — | 120,100 | Mar 31, 2009 |
| TULLY KEVIN P | Executive VP & CFO | Tax Withholding | 111,646 | $1.00 | $111,646 | 377,344 | Mar 31, 2009 |
| SHAROKY MELVIN MD | — | Award / Grant | 120,000 | — | — | 512,670 | Mar 31, 2009 |
| Lanfear Dennis M | — | Award / Grant | 120,000 | — | — | 120,000 | Mar 31, 2009 |
| Farrar Doug | Vice President, ITP | Tax Withholding | 97,966 | $1.00 | $97,966 | 292,055 | Mar 31, 2009 |
| ALLAN GEOFFREY | President, CEO and Chairman | Disposition | 531,156 | $1.00 | $531,156 | 1,826,682 | Mar 31, 2009 |
| WHITCOMB RANDALL W | — | Award / Grant | 120,000 | — | — | 150,000 | Mar 31, 2009 |
| Glover Steve C | President Follow-on Biologics | Disposition | 232,381 | $1.00 | $232,381 | 368,845 | Mar 31, 2009 |
| Farrar Doug | Sr. VP of Pharmaceutical Op. | Purchase | 15,060 | $0.34 | $5,120 | 44,369 | Dec 31, 2008 |
| TULLY KEVIN P | Executive VP & CFO | Award / Grant | 252,166 | — | — | 394,418 | May 29, 2008 |
| ALLAN GEOFFREY | President, CEO and Chairman | Award / Grant | 660,218 | — | — | 1,826,682 | May 29, 2008 |
| Farrar Doug | Vice President, ITP | Award / Grant | 229,242 | — | — | 258,551 | May 29, 2008 |
| Glover Steve C | President Follow-on Biologics | Award / Grant | 288,845 | — | — | 368,845 | May 29, 2008 |
| SHAROKY MELVIN MD | — | Purchase | 13,400 | $0.80 | $10,720 | 342,470 | Jan 10, 2008 |
| ENGELSEN STEINAR J | — | Purchase | 10,000 | $0.97 | $9,700 | 58,125 | Nov 14, 2007 |
| Farrar Doug | Vice President, ITP | Purchase | 15,420 | $0.69 | $10,640 | 29,309 | Jun 30, 2007 |
| CROOKE GRAHAM K | — | Purchase | 10,000 | $0.84 | $8,400 | 60,000 | Jun 27, 2007 |
| TULLY KEVIN P | Executive VP & CFO | Purchase | 40,800 | $0.79 | $32,232 | 139,752 | Jun 27, 2007 |
| Glover Steve C | President Follow-on Biologics | Purchase | 11,280 | $0.78 | $8,798 | 21,380 | Jun 25, 2007 |